Allogene Therapeutics Inc (ALLO)
NASDAQ:ALLO
US Market
Holding ALLO?
Track your performance easily

Allogene Therapeutics (ALLO) Income Statement

1,301 Followers

Allogene Therapeutics Income Statement

Last quarter (Q3 2024), Allogene Therapeutics's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q3, Allogene Therapeutics's net income was $-66.29M. See Allogene Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ -22.00K$ 95.00K$ 156.00K$ 38.49M--
Cost of Revenue
------
Gross Profit
$ -22.00K$ 95.00K$ 156.00K$ 38.49M--
Operating Expense
$ 284.62M$ 314.59M$ 335.69M$ 294.28M$ 258.24M$ 202.01M
Operating Income
$ -297.88M$ -327.74M$ -335.54M$ -255.79M$ -258.24M$ -202.01M
Net Non Operating Interest Income Expense
$ 20.02M$ 18.31M$ 4.57M$ 1.71M--
Other Income Expense
$ -23.49M$ -31.08M$ -9.44M$ 2.93M$ -9.16M$ -17.35M
Pretax Income
$ -286.81M$ -327.26M$ -340.41M$ -257.00M$ -250.22M$ -184.93M
Tax Provision
$ -21.61M$ -21.61M$ -40.64M$ -692.00K$ -18.66M$ -331.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -286.91M$ -327.26M$ -340.41M$ -182.05M$ -316.38M$ -184.59M
Basic EPS
$ -1.54$ -2.09$ -2.32$ -1.89$ -2.08$ -1.83
Diluted EPS
$ -1.54$ -2.09$ -2.32$ -1.89$ -2.08$ -1.83
Basic Average Shares
$ 737.06M$ 156.93M$ 143.15M$ 135.82M$ 120.37M$ 101.06M
Diluted Average Shares
$ 737.06M$ 156.93M$ 143.15M$ 135.82M$ 120.37M$ 101.06M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 297.86M$ 314.59M$ 335.69M$ 294.28M$ 258.24M$ 202.01M
Net Income From Continuing And Discontinued Operation
$ -286.91M$ -327.26M$ -340.41M$ -182.05M$ -316.38M$ -184.59M
Normalized Income
$ -762.25M$ -774.36M----
Interest Expense
------
EBIT
$ -269.58M$ -314.49M$ -335.54M$ -180.19M$ -258.24M$ -184.93M
EBITDA
$ -255.70M$ -300.29M$ -321.24M$ -169.74M$ -250.66M$ -179.90M
Currency in USD

Allogene Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis